相似文献
1
Optimising corticosteroid treatment for autoimmune pancreatitis.
Gut. 2007 Dec;56(12):1650-2. doi: 10.1136/gut.2007.129833.
2
Diabetes mellitus responsive to corticosteroids in autoimmune pancreatitis.
J Clin Gastroenterol. 2004 Nov-Dec;38(10):910. doi: 10.1097/00004836-200411000-00016.
3
The need for a consensus on the definition of remission of autoimmune pancreatitis after steroid treatment.
Gut. 2010 Dec;59(12):1730. doi: 10.1136/gut.2009.199513. Epub 2010 Aug 30.
4
Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis.
Lancet. 2000 Sep 9;356(9233):910-1. doi: 10.1016/S0140-6736(00)02684-2.
5
Oral steroid versus steroid pulse therapy for autoimmune pancreatitis: time to introduce new weapons.
J Gastroenterol. 2012 Jan;47(1):92-3; author reply 94-5. doi: 10.1007/s00535-011-0468-9. Epub 2011 Sep 20.
6
Radiologic evaluation of autoimmune pancreatitis.
Radiology. 2012 Feb;262(2):731-2; author reply 732. doi: 10.1148/radiol.11111706.
7
Renal lesions in autoimmune pancreatitis: diffusion weighted magnetic resonance imaging for assessing response to corticosteroid therapy.
JOP. 2013 Sep 10;14(5):506-9. doi: 10.6092/1590-8577/1400.
8
Correlation between long-term outcome and steroid therapy in type 1 autoimmune pancreatitis: relapse, malignancy and side effect of steroid.
Scand J Gastroenterol. 2015;50(11):1411-8. doi: 10.3109/00365521.2015.1054424. Epub 2015 Jun 10.
9
Autoimmune chronic pancreatitis relapsing despite the maintenance dose of steroid.
Korean J Intern Med. 2005 Jun;20(2):163-7. doi: 10.3904/kjim.2005.20.2.163.
10
Incidence and outcome of lung involvement in IgG4-related autoimmune pancreatitis.
Respirology. 2015 Oct;20(7):1142-4. doi: 10.1111/resp.12599. Epub 2015 Jul 17.
引用本文的文献
1
Autoimmune pancreatitis: A bibliometric analysis from 2002 to 2022.
Front Immunol. 2023 Feb 22;14:1135096. doi: 10.3389/fimmu.2023.1135096. eCollection 2023.
2
Challenges for clinicians treating autoimmune pancreatitis: Current perspectives.
World J Clin Cases. 2023 Jan 6;11(1):30-46. doi: 10.12998/wjcc.v11.i1.30.
3
Current status of type 1 (IgG4-related) autoimmune pancreatitis.
J Gastroenterol. 2022 Oct;57(10):695-708. doi: 10.1007/s00535-022-01891-7. Epub 2022 Aug 2.
4
In-Hospital Patient Education Markedly Reduces Alcohol Consumption after Alcohol-Induced Acute Pancreatitis.
Nutrients. 2022 May 20;14(10):2131. doi: 10.3390/nu14102131.
5
The Clinical Phenotype of Chinese Patients With Autoimmune Pancreatitis Differs Significantly From Western Patients.
Front Med (Lausanne). 2022 Mar 7;9:771784. doi: 10.3389/fmed.2022.771784. eCollection 2022.
6
IgG4-related tubulointerstitial nephritis.
BMJ Case Rep. 2021 Nov 11;14(11):e241942. doi: 10.1136/bcr-2021-241942.
7
Clinical practice guidelines for IgG4-related sclerosing cholangitis.
J Hepatobiliary Pancreat Sci. 2019 Jan;26(1):9-42. doi: 10.1002/jhbp.596. Epub 2019 Jan 18.
8
Clinical and pathophysiological aspects of type 1 autoimmune pancreatitis.
J Gastroenterol. 2018 Apr;53(4):475-483. doi: 10.1007/s00535-018-1440-8. Epub 2018 Feb 19.
9
Rituximab was used to treat recurrent IgG4-related hypophysitis with ophthalmopathy as the initial presentation: A case report and literature review.
Medicine (Baltimore). 2017 Jun;96(24):e6934. doi: 10.1097/MD.0000000000006934.
10
Acute Painful Ptosis Secondary to IgG4 Dacryoadenitis.
Case Rep Ophthalmol. 2016 Feb 20;7(1):108-11. doi: 10.1159/000444164. eCollection 2016 Jan-Apr.
本文引用的文献
1
Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment.
Gut. 2007 Dec;56(12):1719-24. doi: 10.1136/gut.2006.115246. Epub 2007 May 24.
2
Prognosis of autoimmune pancreatitis.
J Gastroenterol. 2007 May;42 Suppl 18:59-62. doi: 10.1007/s00535-007-2052-x.
3
Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.
Clin Gastroenterol Hepatol. 2006 Aug;4(8):1010-6; quiz 934. doi: 10.1016/j.cgh.2006.05.017. Epub 2006 Jul 14.
4
Autoimmune pancreatocholangitis: a series of ten patients.
Scand J Gastroenterol Suppl. 2006(243):70-8. doi: 10.1080/00365520600664326.
5
Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy.
Intern Med. 2006;45(8):497-501. doi: 10.2169/internalmedicine.45.1565. Epub 2006 May 15.
6
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.
Ann Rheum Dis. 2006 Mar;65(3):285-93. doi: 10.1136/ard.2005.038638. Epub 2005 Aug 17.
7
Treating patients with autoimmune pancreatitis: results from a long-term follow-up study.
Pancreatology. 2005;5(2-3):234-8; discussion 238-40. doi: 10.1159/000085277. Epub 2005 Apr 22.
8
Biliary tract involvement in autoimmune pancreatitis.
Pancreas. 2005 Jan;30(1):76-82.
9
Long-term prognosis of duct-narrowing chronic pancreatitis: strategy for steroid treatment.
Pancreas. 2005 Jan;30(1):31-9.
10
Morphological changes after steroid therapy in autoimmune pancreatitis.
Scand J Gastroenterol. 2004 Nov;39(11):1154-8. doi: 10.1080/00365520410008033.
Zotero 插件